| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2283870A1 Oligonucleotides inhibiting cellular migration |
| 02/16/2011 | EP2283860A2 Use for interleukin-33 (il-33) and the il-33 receptor complex |
| 02/16/2011 | EP2283859A2 Pantropic canine coronavirus |
| 02/16/2011 | EP2283810A1 Orally administered bacteria as vehicles for systemic delivery of agents |
| 02/16/2011 | EP2282776A1 Apoptosis inducer |
| 02/16/2011 | EP2282764A1 Liver-specific nucleic acid regulatory elements and methods and use thereof |
| 02/16/2011 | EP2061433B1 Compositions for enhancing transport through mucus |
| 02/16/2011 | EP1766010B1 Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
| 02/16/2011 | EP1469077B1 Cell-specific expression/replication vector |
| 02/16/2011 | EP0871754B1 Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant |
| 02/16/2011 | CN101978060A Novel fer -like protein, pharmaceutical compositions containing it and method for its use |
| 02/16/2011 | CN101978059A Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 02/16/2011 | CN101977632A Compositions for enhanced uptake of viral vectors in the myocardium |
| 02/16/2011 | CN101977629A Therapeutic agent for fibroid lung |
| 02/16/2011 | CN101974557A Bifidobacterium pBES-tk recombinant vector for targeted therapy of solid tumor and application thereof |
| 02/16/2011 | CN101974534A NRG1 gene coding sequence and application thereof |
| 02/16/2011 | CN101974533A siRNA molecule inhibiting Bc1-2 gene expression and application thereof |
| 02/16/2011 | CN101974532A SiRNA molecule for interfering expression of Bcl-2 gene and application thereof |
| 02/16/2011 | CN101974529A TGF-beta specific siRNA containing free triphosphoric acid group and application thereof |
| 02/16/2011 | CN101974229A Polylactic acid-polyethylene glycol/europium doped calcium phosphate nano composite material, modified substance thereof and preparation of both |
| 02/16/2011 | CN101974152A Lipoid-cation polymer and preparation method thereof |
| 02/16/2011 | CN101972483A RNAI-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions |
| 02/16/2011 | CN101972482A Chicken infectious laryngotracheitis bivalent nucleic acid vaccine and preparation method thereof |
| 02/16/2011 | CN101972476A DNA vaccine adjuvant using Micro RNA-155 and construction method thereof |
| 02/16/2011 | CN101972275A Gene treatment using TGF-beta secretion cell |
| 02/16/2011 | CN101518483B Biological vision assisting system |
| 02/16/2011 | CN101509002B Recombinant rubella virus protein and uses thereof |
| 02/16/2011 | CN101072878B Recombinant vector containing MJ1 gene and method of recombinant method using the same |
| 02/16/2011 | CN101031579B Small RNA and methods for inhibiting same |
| 02/15/2011 | USRE42150 Binding proteins for recognition of DNA |
| 02/15/2011 | US7888458 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 02/15/2011 | US7888327 Methods of using immunostimulatory nucleic acid molecules to treat allergic conditions |
| 02/15/2011 | US7888326 Methods for promoting apoptosis and treating tumor cells inhibiting the expression or function of the transcription factor ATF5 |
| 02/15/2011 | US7888320 Composition for treating cancer adapted for intra-tumoral administration and uses thereof |
| 02/15/2011 | US7888114 encoding a Herpesviridae thymidine kinase enzyme comprising one or more mutations; for gene therapy, cancer |
| 02/15/2011 | US7888097 Formulation for adenovirus storage |
| 02/15/2011 | US7888096 Liquid adenovirus formulations |
| 02/15/2011 | US7888092 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 02/15/2011 | US7888091 Fusion proteins having thymidine kinase and guanylate kinase activities |
| 02/15/2011 | US7888089 Nucleotide sequences coding polypeptide for use in the treatment of cardivascular, restenosis, hypertension, atherosclerosis, heart defects, diabetes and neovascularization disorders; endothelial nitric oxide synthase (eNOS) |
| 02/15/2011 | US7888076 Collagen-like protein CLAC, precursor thereof and genes encoding the same |
| 02/15/2011 | US7888038 modulating apoptosis-induced cell death comprising modulating the level of Bak Binding Protein (BBP) in a eukaryotic cell; drug screening |
| 02/15/2011 | US7887833 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/15/2011 | US7887816 Attenuated microorganisms for the treatment of infection |
| 02/15/2011 | US7887806 Mammalian receptor proteins DCRS5; method of treatment |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | US7887798 Methods of treating cancer by administering antibodies to CD200 |
| 02/15/2011 | US7887796 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1 |
| 02/15/2011 | US7887793 for enhancing the proliferation and fusion of transplanted cells thereby to increase muscle mass or to prevent or treat muscle disease associated with a genetic defect |
| 02/15/2011 | US7887792 Muscle-derived cells (MDCs) for treating muscle- or bone-related injury or dysfunction |
| 02/15/2011 | US7887581 Methods of hemodialysis utilizing grafts coated with cells expressing human fibulin-5 |
| 02/15/2011 | CA2628883C Novel 3'-modified oligonucleotide derivatives |
| 02/15/2011 | CA2452445C Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 02/15/2011 | CA2433071C Use of transcription factor yb-1 in adenoviral systems |
| 02/15/2011 | CA2356701C Gene therapy for diabetic ischemic disease |
| 02/10/2011 | WO2011017516A2 Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins) |
| 02/10/2011 | WO2011017456A2 Localized delivery of nanoparticles for therapeutic and diagnostic applications |
| 02/10/2011 | WO2011017404A2 Retroelements and mental disorders and methods of measuring l1 retrotransposition |
| 02/10/2011 | WO2011017315A2 Methods and compositions for targeted gene modification |
| 02/10/2011 | WO2011017313A1 Method of administering non-viral nucleic acid vectors to the eye |
| 02/10/2011 | WO2011017297A2 Biodegradable delivery system complexes for the delivery of bioactive compounds |
| 02/10/2011 | WO2011017137A2 Methods and compositions for treating insects |
| 02/10/2011 | WO2011016840A2 Methods and compositions for treating trinucleotide repeat disorders |
| 02/10/2011 | WO2011016561A1 Dna capable of inducing osteoblast-specific expression, and nucleotide sequence for same |
| 02/10/2011 | WO2011016461A1 Tumor angiogenesis inhibitor |
| 02/10/2011 | WO2011016026A2 Novel proteins |
| 02/10/2011 | WO2011015720A1 Use of microrna for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells |
| 02/10/2011 | WO2011015593A1 Methods and compounds for the diagnosis and treatment of cancer |
| 02/10/2011 | WO2011015573A1 Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases |
| 02/10/2011 | WO2011015347A1 Vaccine composition comprising 5'-cap modified rna |
| 02/10/2011 | US20110035819 Codon optimized cftr |
| 02/10/2011 | US20110035817 Siva 3, its preparation and use |
| 02/10/2011 | US20110034752 Therapeutic regimen for treating cancer |
| 02/10/2011 | US20110034544 COMPOSITIONS COMPRISING GHRH AND GnRH AND METHODS OF USING THE SAME |
| 02/10/2011 | US20110034543 DNA Vaccination For Treatment of Multiple Sclerosis and Insulin-Dependent Diabetes Mellitus |
| 02/10/2011 | US20110034541 Inhibitors of DNA Immunostimulatory Sequence Activity |
| 02/10/2011 | US20110034539 Methods for treating blood coagulation disorders |
| 02/10/2011 | US20110034379 Gastrin Compositions And Formulations, And Methods Of Use And Preparation |
| 02/10/2011 | US20110033489 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 02/10/2011 | US20110033429 Inducible Gene Expression |
| 02/10/2011 | US20110033424 Use of adenovirus and nucleic acids coding therefor |
| 02/10/2011 | DE10164805B4 Verfahren und Mittel zur Modifikation humaner Angiogenese Method and means for modification of human angiogenesis |
| 02/10/2011 | CA2769665A1 Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins) |
| 02/10/2011 | CA2769230A1 Use of microrna for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells |
| 02/10/2011 | CA2768600A1 Vaccine composition comprising 5'-cap modified rna |
| 02/09/2011 | EP2282208A1 Methods and compounds for the diagnosis and treatment of cancer |
| 02/09/2011 | EP2281897A2 Oncolytic mutant Herpes Simplex virus |
| 02/09/2011 | EP2281884A1 Mesothelioma-specific promoter and use thereof |
| 02/09/2011 | EP2281874A1 Production of ß-Cells |
| 02/09/2011 | EP2281832A2 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 02/09/2011 | EP2281579A1 Vaccine composition comprising 5'-Cap modified RNA |
| 02/09/2011 | EP2281033A1 Post release modification of viral envelopes |
| 02/09/2011 | EP2281011A2 Diblock copolymers and polynucleotide complexes thereof for delivery into cells |
| 02/09/2011 | EP2281007A2 Anti-atheroma vaccine |
| 02/09/2011 | EP1742668B1 Sequential delivery of immunogenic molecules via adenovirus and adeno-associated virus-mediated administrations |
| 02/09/2011 | EP1716869B1 Drug for preventing or treating heart diseases comprising cd9 gene |
| 02/09/2011 | EP1648931B1 Multifunctional cytokines |
| 02/09/2011 | EP1573046B1 Protease resistant ti-growth hormone releasing hormone |
| 02/09/2011 | EP1504098B2 A method for in vitro molecular evolution of protein function |